Padua, Italy

Francesco Tisato

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 5.3

ph-index = 2

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2001-2015

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Francesco Tisato

Introduction

Francesco Tisato is a notable inventor based in Padua, Italy. He has made significant contributions to the field of medical chemistry, particularly in the development of compounds for cancer treatment. With a total of 6 patents, Tisato's work has the potential to impact the lives of many patients suffering from solid tumors.

Latest Patents

One of Tisato's latest patents involves the creation of [CU(thp)4]n[X]-n compounds for the treatment of a broad range of human solid tumors, including refractory tumors. These Cu(I) complexes are designed as antineoplastic agents against solid tumors in humans. Another significant patent is an intermediate compound of technetium nitride complex for radiodiagnostic imaging. This bisphosphonoamine compound is extremely useful for preparing a technetium nitride complex, which is essential for effective radiodiagnostic imaging.

Career Highlights

Throughout his career, Tisato has worked with prominent companies in the medical imaging and pharmaceutical sectors. Notable among these are Nihon Medi-Physics Company, Limited and Bracco Imaging S.p.A. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking innovations in medical technology.

Collaborations

Tisato has collaborated with several talented individuals in his field. Among his coworkers are Cristina Bolzati and Fiorenzo Refosco, who have contributed to his research and development efforts.

Conclusion

Francesco Tisato's innovative work in the field of medical chemistry showcases his dedication to improving cancer treatment and diagnostic imaging. His patents reflect a commitment to advancing healthcare through scientific research and collaboration.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…